Linux Laboratories Pvt. Ltd.

Linux Laboratories Pvt. Ltd.

Linux Laboratories Pvt. Ltd.

March 2021

Announced Date: March 2021

Value: Undisclosed

Linux Laboratories Pvt. Ltd. (“Linux”), has raised equity capital from Tata Healthcare Fund II (“TCHF II”). Investment proceeds from TCHF II will support augmentation of the current product portfolio and expansion into new therapeutic areas. o3 Capital was the sole financial advisor to Linux for this transaction.

Linux is amongst the fastest growing CNS focused pharmaceutical companies in India and has established itself in the top 40 companies in the segment, which is traditionally dominated by large players.

Commenting on the announcement, Mr. P. Hariharan, Co-founder and Director, Linux said, “We at Linux are committed towards providing high quality and affordable medicines across the length and breadth of the Country. It has been an interesting journey for Linux since its inception in 2007, and this growth capital infusion and partnership with a seasoned investor like Tata Capital Healthcare Fund will mark a new journey in Linux’s growth while staying true to the company's founding principles.”

“Tata Capital Healthcare Fund II is excited to partner with Linux in their growth journey. Since inception, Linux has established an impressive track record of growth in India’s branded formulations market. Through a disciplined and differentiated approach, to creating value for customers, Linux is well positioned for the next leg of growth” said Ms. Visalakshi Chandramouli, Managing Partner, Tata Capital Healthcare Fund.